These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17590923)

  • 1. [Cancer of the prostate (2): genomic studies and investigation of markers].
    Ardaillou R
    Med Sci (Paris); 2007 May; 23(5):493. PubMed ID: 17590923
    [No Abstract]   [Full Text] [Related]  

  • 2. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated genes as new cancer biomarkers.
    Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
    Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic predisposition to prostate cancer].
    Jeanteur P
    Bull Cancer; 2008 Nov; 95(11):1063-6. PubMed ID: 19036678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of prostate cancer with emphasis on genetic markers.
    Aly M; Wiklund F; Grönberg H
    Acta Oncol; 2011 Jun; 50 Suppl 1():18-23. PubMed ID: 21604936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five genetic variants associated with prostate cancer.
    Gartner CE; Barendregt JJ; Hall WD
    N Engl J Med; 2008 Jun; 358(25):2738-9; author reply 2741. PubMed ID: 18572445
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic heterogeneity of 8q24 region in susceptibility to cancer.
    Wokołorczyk D; Lubiński J; Narod SA; Cybulski C
    J Natl Cancer Inst; 2009 Feb; 101(4):278-9. PubMed ID: 19211453
    [No Abstract]   [Full Text] [Related]  

  • 8. The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
    Langsenlehner T; Langsenlehner U; Renner W; Kapp KS; Krippl P; Hofmann G; Clar H; Pummer K; Mayer R
    Prostate; 2008 Feb; 68(3):264-8. PubMed ID: 18163425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a new intronic polymorphism of the SOD2 gene (G1677T) with cancer.
    Hernandez-Saavedra D; McCord JM
    Cell Biochem Funct; 2009 Jun; 27(4):223-7. PubMed ID: 19405048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic epidemiology of cancer: relatively risky relatives.
    Pharoah P
    Eur J Hum Genet; 2005 May; 13(5):519-20. PubMed ID: 15741990
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular biology and prostate cancer: evolution or revolution?].
    Molinié V; Beuzeboc P; Mahjoub WK;
    Ann Pathol; 2008 Oct; 28(5):354-62. PubMed ID: 19068390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic markers and the risk of developing prostate cancer.
    Bjartell A
    Eur Urol; 2011 Jul; 60(1):29-31. PubMed ID: 21420228
    [No Abstract]   [Full Text] [Related]  

  • 13. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic gestalt.
    Kiser K
    Minn Med; 2005 Apr; 88(4):11-2. PubMed ID: 15940884
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
    Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
    Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of incorporating genetic variants for the early detection of prostate cancer.
    Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
    Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser Capture Microdissection: a rising tool in genetic profiling of cancer.
    Lechpammer M; Sgroi DC
    Expert Rev Mol Diagn; 2004 Jul; 4(4):429-30. PubMed ID: 15225089
    [No Abstract]   [Full Text] [Related]  

  • 18. Can managed care put genetic testing to good use?
    Med Interface; 1997 Jun; 10(6):66-7. PubMed ID: 10169009
    [No Abstract]   [Full Text] [Related]  

  • 19. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
    Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
    Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.
    Johansson M; McKay JD; Rinaldi S; Wiklund F; Adami HO; Grönberg H; Kaaks R; Stattin P
    Prostate; 2009 Sep; 69(12):1281-91. PubMed ID: 19455605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.